Oxidative post-translational modifications of α-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease

被引:158
|
作者
Przedborski, S
Chen, QP
Vila, M
Giasson, BI
Djaldatti, R
Vukosavic, S
Souza, JM
Jackson-Lewis, V
Lee, VMY
Ischiropoulos, H
机构
[1] Columbia Univ, Dept Neurol, Neurosci Res Movement Disorder Div, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, New York, NY 10032 USA
[3] Childrens Hosp Philadelphia, Stokes Res Inst, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Dept Biochem & Biophys, Philadelphia, PA 19104 USA
[5] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
dopaminergic neurons; MPTP; neurodegeneration; Parkinson's disease; substantia nigra; synuclein;
D O I
10.1046/j.1471-4159.2001.00174.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Structural and functional alterations of alpha -synuclein is a presumed culprit in the demise of dopaminergic neurons in Parkinson's disease (PD), alpha -Synuclein mutations are found in familial but not in sporadic PD, raising the hypothesis that effects similar to those of familial PD-linked alpha -synuclein mutations may be achieved by oxidative post-translational modifications. Here, we show that wild-type alpha -synuclein is a selective target for nitration following peroxynitrite exposure of stably transfected HEK293 cells. Nitration of alpha -synuclein also occurs in the mouse striatum and Ventral midbrain following administration of the parkinsonian neurotoxin 1-methyt-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Conversely, beta -synuclein and synaptophysin were not nitrated in MPTP-intoxicated mice. Our data demonstrate that alpha -synuclein is a target for tyrosine nitration, which, by disrupting its biophysical properties, may be relevant to the putative role of alpha -synuclein in the neurodegeneration associated with MPTP toxicity and with PD.
引用
收藏
页码:637 / 640
页数:4
相关论文
共 50 条
  • [21] Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
    Xu, K
    Xu, YH
    Brown-Jermyn, D
    Chen, JF
    Ascherio, A
    Dluzen, DE
    Schwarzschild, MA
    JOURNAL OF NEUROSCIENCE, 2006, 26 (02): : 535 - 541
  • [22] Sympathetic innervation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease
    Goldstein, DS
    Li, ST
    Holmes, C
    Bankiewicz, K
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 306 (03): : 855 - 860
  • [23] STUDIES ON THE MECHANISM OF ACTION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)
    COHEN, G
    MYTILINEOU, C
    LIFE SCIENCES, 1985, 36 (03) : 237 - 242
  • [24] METABOLISM OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MOUSE-LIVER PREPARATIONS
    BAKER, JK
    BORNE, RF
    DAVIS, WM
    WATERS, IW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 125 (02) : 484 - 490
  • [25] Catalpol Exerts Neuroprotective Effect on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Mouse Model of Parkinson's Disease and the Underlying Mechanisms
    Li, Xueqian
    Zhao, Chengzhi
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2021, 11 (08) : 1506 - 1516
  • [26] Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease
    Wu, DC
    Jackson-Lewis, V
    Vila, M
    Tieu, K
    Teismann, P
    Vadseth, C
    Choi, DK
    Ischiropoulos, H
    Przedborski, S
    JOURNAL OF NEUROSCIENCE, 2002, 22 (05): : 1763 - 1771
  • [27] PLACENTAL TOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN MICE
    SCHMAHL, W
    USLER, B
    TOXICOLOGY, 1991, 67 (01) : 63 - 74
  • [28] ON THE MECHANISMS UNDERLYING 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) NEUROTOXICITY
    HARIK, SI
    IACOFANO, LA
    SAYRE, LM
    ARORA, PK
    BLUE, P
    SCHMIDLEY, JW
    NEUROLOGY, 1986, 36 (04) : 288 - 289
  • [29] SULFHYDRYL DRUGS REDUCE NEUROTOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) IN THE MOUSE
    OISHI, T
    HASEGAWA, E
    MURAI, Y
    JOURNAL OF NEURAL TRANSMISSION-PARKINSONS DISEASE AND DEMENTIA SECTION, 1993, 6 (01) : 45 - 52
  • [30] Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson's disease
    Kadoguchi, Naoto
    Okabe, Shinji
    Yamamura, Yukio
    Shono, Misaki
    Fukano, Tatsuya
    Tanabe, Akie
    Yokoyama, Hironori
    Kasahara, Jiro
    BMC NEUROSCIENCE, 2014, 15